Article info
Original article
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma
- Correspondence to Associate Professor Wendy Cooper, Tissue Pathology and Diagnostic Pathology, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia; wendy.cooper{at}sswahs.nsw.gov.au
Citation
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma
Publication history
- Received March 8, 2013
- Revised April 8, 2013
- Accepted May 9, 2013
- First published June 11, 2013.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions